nodes	percent_of_prediction	percent_of_DWPC	metapath
MACITENTAN—CYP2C19—urine—polycystic ovary syndrome	0.0292	0.0906	CbGeAlD
MACITENTAN—EDNRB—adrenal cortex—polycystic ovary syndrome	0.0219	0.068	CbGeAlD
MACITENTAN—EDNRB—endometrium—polycystic ovary syndrome	0.0196	0.0608	CbGeAlD
MACITENTAN—EDNRA—adrenal cortex—polycystic ovary syndrome	0.0181	0.0562	CbGeAlD
MACITENTAN—EDNRB—uterus—polycystic ovary syndrome	0.018	0.056	CbGeAlD
MACITENTAN—EDNRB—pituitary gland—polycystic ovary syndrome	0.0177	0.055	CbGeAlD
MACITENTAN—EDNRB—adipose tissue—polycystic ovary syndrome	0.0176	0.0548	CbGeAlD
MACITENTAN—CYP3A4—urine—polycystic ovary syndrome	0.0173	0.0536	CbGeAlD
MACITENTAN—EDNRA—endometrium—polycystic ovary syndrome	0.0162	0.0502	CbGeAlD
MACITENTAN—EDNRB—adrenal gland—polycystic ovary syndrome	0.0158	0.0491	CbGeAlD
MACITENTAN—EDNRA—uterus—polycystic ovary syndrome	0.0149	0.0463	CbGeAlD
MACITENTAN—EDNRB—female gonad—polycystic ovary syndrome	0.0147	0.0458	CbGeAlD
MACITENTAN—EDNRB—vagina—polycystic ovary syndrome	0.0147	0.0455	CbGeAlD
MACITENTAN—EDNRA—pituitary gland—polycystic ovary syndrome	0.0146	0.0454	CbGeAlD
MACITENTAN—EDNRA—adipose tissue—polycystic ovary syndrome	0.0146	0.0453	CbGeAlD
MACITENTAN—EDNRA—adrenal gland—polycystic ovary syndrome	0.0131	0.0406	CbGeAlD
MACITENTAN—EDNRA—female gonad—polycystic ovary syndrome	0.0122	0.0379	CbGeAlD
MACITENTAN—EDNRA—vagina—polycystic ovary syndrome	0.0121	0.0376	CbGeAlD
MACITENTAN—ALB—adrenal gland—polycystic ovary syndrome	0.00693	0.0215	CbGeAlD
MACITENTAN—CYP2C19—vagina—polycystic ovary syndrome	0.00517	0.0161	CbGeAlD
MACITENTAN—CYP2C19—endocrine gland—polycystic ovary syndrome	0.00484	0.015	CbGeAlD
MACITENTAN—CYP3A4—endocrine gland—polycystic ovary syndrome	0.00286	0.00888	CbGeAlD
MACITENTAN—CYP2C19—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000403	0.000595	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—SERPINE1—polycystic ovary syndrome	0.000402	0.000593	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP1A1—polycystic ovary syndrome	0.000401	0.000592	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRA1A—polycystic ovary syndrome	0.0004	0.00059	CbGpPWpGaD
MACITENTAN—CYP3A4—Oxidation by Cytochrome P450—CYP1A1—polycystic ovary syndrome	0.000396	0.000584	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FST—polycystic ovary syndrome	0.00039	0.000575	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—ADRB2—polycystic ovary syndrome	0.000387	0.000571	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000387	0.000571	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRB3—polycystic ovary syndrome	0.000385	0.000568	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—SERPINE1—polycystic ovary syndrome	0.000383	0.000565	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000383	0.000565	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000381	0.000562	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LHB—polycystic ovary syndrome	0.00038	0.000561	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PGR—polycystic ovary syndrome	0.000377	0.000557	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—SERPINE1—polycystic ovary syndrome	0.000372	0.000549	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PDE3B—polycystic ovary syndrome	0.000372	0.000549	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GNRH1—polycystic ovary syndrome	0.000372	0.000548	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000363	0.000535	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKR1C1—polycystic ovary syndrome	0.00036	0.000531	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—GNAS—polycystic ovary syndrome	0.000359	0.00053	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SCT—polycystic ovary syndrome	0.000356	0.000526	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000356	0.000526	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—AKR1C1—polycystic ovary syndrome	0.000352	0.00052	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—ADRB2—polycystic ovary syndrome	0.000352	0.000519	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000351	0.000518	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000351	0.000517	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000351	0.000517	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000346	0.000511	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PNPLA2—polycystic ovary syndrome	0.000344	0.000507	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—MTNR1B—polycystic ovary syndrome	0.00034	0.000501	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000338	0.000499	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ATF1—polycystic ovary syndrome	0.000335	0.000494	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—FGF18—polycystic ovary syndrome	0.000334	0.000493	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—RBP4—polycystic ovary syndrome	0.000331	0.000489	CbGpPWpGaD
MACITENTAN—EDNRA—Gastrin-CREB signalling pathway via PKC and MAPK—IL6—polycystic ovary syndrome	0.00033	0.000487	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—SULT2A1—polycystic ovary syndrome	0.000329	0.000485	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000326	0.000481	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—GNAS—polycystic ovary syndrome	0.000326	0.000481	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—SRD5A1—polycystic ovary syndrome	0.000326	0.000481	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—CYP1A1—polycystic ovary syndrome	0.000325	0.00048	CbGpPWpGaD
MACITENTAN—EDNRB—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000325	0.000479	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—SULT2A1—polycystic ovary syndrome	0.000324	0.000478	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—RACGAP1—polycystic ovary syndrome	0.000319	0.00047	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—STAR—polycystic ovary syndrome	0.000311	0.000458	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—YAP1—polycystic ovary syndrome	0.000309	0.000456	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000309	0.000456	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—POMC—polycystic ovary syndrome	0.000307	0.000453	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—PRL—polycystic ovary syndrome	0.000306	0.000452	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GAB1—polycystic ovary syndrome	0.000305	0.00045	CbGpPWpGaD
MACITENTAN—ALB—SLC-mediated transmembrane transport—SLC2A4—polycystic ovary syndrome	0.000303	0.000447	CbGpPWpGaD
MACITENTAN—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—polycystic ovary syndrome	0.000299	0.000441	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000295	0.000435	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000294	0.000434	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—INSR—polycystic ovary syndrome	0.000292	0.00043	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP11A1—polycystic ovary syndrome	0.000291	0.00043	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.00029	0.000428	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP11A1—polycystic ovary syndrome	0.000287	0.000424	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000287	0.000424	CbGpPWpGaD
MACITENTAN—CYP2C19—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.000283	0.000418	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NMNAT3—polycystic ovary syndrome	0.000281	0.000415	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKR1C3—polycystic ovary syndrome	0.000277	0.000409	CbGpPWpGaD
MACITENTAN—ALB—Platelet degranulation—VEGFA—polycystic ovary syndrome	0.000276	0.000408	CbGpPWpGaD
MACITENTAN—ALB—Vitamin B12 Metabolism—IL6—polycystic ovary syndrome	0.000274	0.000404	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TNRC6B—polycystic ovary syndrome	0.000273	0.000402	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—AKR1C3—polycystic ovary syndrome	0.000271	0.0004	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP17A1—polycystic ovary syndrome	0.000271	0.000399	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PGR—polycystic ovary syndrome	0.00027	0.000398	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000269	0.000397	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000268	0.000396	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP17A1—polycystic ovary syndrome	0.000267	0.000394	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B1—polycystic ovary syndrome	0.000264	0.00039	CbGpPWpGaD
MACITENTAN—ALB—Response to elevated platelet cytosolic Ca2+—VEGFA—polycystic ovary syndrome	0.000263	0.000388	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000262	0.000387	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SUOX—polycystic ovary syndrome	0.000257	0.00038	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LPCAT2—polycystic ovary syndrome	0.000257	0.00038	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000257	0.000378	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000254	0.000375	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NMNAT3—polycystic ovary syndrome	0.000253	0.000373	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—NRG1—polycystic ovary syndrome	0.000252	0.000371	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PLAT—polycystic ovary syndrome	0.000251	0.00037	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GHRL—polycystic ovary syndrome	0.000251	0.00037	CbGpPWpGaD
MACITENTAN—CYP3A4—Phase 1 - Functionalization of compounds—POMC—polycystic ovary syndrome	0.000242	0.000358	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—POMC—polycystic ovary syndrome	0.000242	0.000357	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—LHB—polycystic ovary syndrome	0.000241	0.000355	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ATF1—polycystic ovary syndrome	0.00024	0.000353	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—ISYNA1—polycystic ovary syndrome	0.000239	0.000353	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—HSD3B2—polycystic ovary syndrome	0.000236	0.000347	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.000234	0.000345	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—TCF7L2—polycystic ovary syndrome	0.000234	0.000345	CbGpPWpGaD
MACITENTAN—EDNRA—GPCR downstream signaling—AKT2—polycystic ovary syndrome	0.000233	0.000343	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LPCAT2—polycystic ovary syndrome	0.000231	0.000341	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SUOX—polycystic ovary syndrome	0.000231	0.000341	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C1—polycystic ovary syndrome	0.000228	0.000336	CbGpPWpGaD
MACITENTAN—ALB—Folate Metabolism—IL6—polycystic ovary syndrome	0.000223	0.000329	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NGFR—polycystic ovary syndrome	0.000221	0.000326	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—POMC—polycystic ovary syndrome	0.00022	0.000324	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—PRL—polycystic ovary syndrome	0.000219	0.000323	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000218	0.000322	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000216	0.000318	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—ISYNA1—polycystic ovary syndrome	0.000215	0.000317	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP19A1—polycystic ovary syndrome	0.000214	0.000316	CbGpPWpGaD
MACITENTAN—CYP2C19—Biological oxidations—POMC—polycystic ovary syndrome	0.000214	0.000316	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP19A1—polycystic ovary syndrome	0.000211	0.000312	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—AKT2—polycystic ovary syndrome	0.000211	0.000311	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—LEP—polycystic ovary syndrome	0.000211	0.000311	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—SULT2A1—polycystic ovary syndrome	0.00021	0.00031	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—ADRB2—polycystic ovary syndrome	0.000208	0.000307	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000207	0.000306	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TEAD2—polycystic ovary syndrome	0.000203	0.0003	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKR1C2—polycystic ovary syndrome	0.000203	0.0003	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—YAP1—polycystic ovary syndrome	0.000196	0.000289	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000196	0.000289	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—PLAT—polycystic ovary syndrome	0.000195	0.000287	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—GNAS—polycystic ovary syndrome	0.000193	0.000284	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000193	0.000284	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000188	0.000278	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—IGF1—polycystic ovary syndrome	0.000188	0.000277	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—AKT2—polycystic ovary syndrome	0.000188	0.000277	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP11A1—polycystic ovary syndrome	0.000186	0.000274	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NCOR1—polycystic ovary syndrome	0.000184	0.000271	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKR1C2—polycystic ovary syndrome	0.000183	0.000269	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TEAD2—polycystic ovary syndrome	0.000183	0.000269	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—POMC—polycystic ovary syndrome	0.000181	0.000267	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—TFRC—polycystic ovary syndrome	0.000181	0.000267	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—INS—polycystic ovary syndrome	0.00018	0.000266	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—NRG1—polycystic ovary syndrome	0.00018	0.000266	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—SERPINE1—polycystic ovary syndrome	0.000178	0.000263	CbGpPWpGaD
MACITENTAN—ALB—Selenium Micronutrient Network—IL6—polycystic ovary syndrome	0.000177	0.000261	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—AKR1C3—polycystic ovary syndrome	0.000176	0.000259	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000174	0.000257	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000174	0.000257	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP17A1—polycystic ovary syndrome	0.000173	0.000255	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—CYP1A1—polycystic ovary syndrome	0.000173	0.000255	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PNPLA2—polycystic ovary syndrome	0.00017	0.000251	CbGpPWpGaD
MACITENTAN—CYP3A4—Metapathway biotransformation—CYP1A1—polycystic ovary syndrome	0.00017	0.000251	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—PLAT—polycystic ovary syndrome	0.000169	0.000249	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000166	0.000244	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SRD5A1—polycystic ovary syndrome	0.000162	0.000238	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IRS2—polycystic ovary syndrome	0.000154	0.000228	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—STAR—polycystic ovary syndrome	0.000154	0.000227	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—SLC2A4—polycystic ovary syndrome	0.000154	0.000227	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PNPLA2—polycystic ovary syndrome	0.000153	0.000226	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000152	0.000225	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NMNAT3—polycystic ovary syndrome	0.000152	0.000224	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—LEP—polycystic ovary syndrome	0.000151	0.000223	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—GNAS—polycystic ovary syndrome	0.000149	0.00022	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SRD5A1—polycystic ovary syndrome	0.000145	0.000214	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LPCAT2—polycystic ovary syndrome	0.000139	0.000205	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SUOX—polycystic ovary syndrome	0.000139	0.000205	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—STAR—polycystic ovary syndrome	0.000138	0.000204	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HMMR—polycystic ovary syndrome	0.000137	0.000203	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP19A1—polycystic ovary syndrome	0.000137	0.000202	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IRS1—polycystic ovary syndrome	0.000135	0.000199	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling by GPCR—IL6—polycystic ovary syndrome	0.000133	0.000197	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HSD3B1—polycystic ovary syndrome	0.000131	0.000193	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—POMC—polycystic ovary syndrome	0.00013	0.000191	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.00013	0.000191	CbGpPWpGaD
MACITENTAN—ALB—Transmembrane transport of small molecules—GNAS—polycystic ovary syndrome	0.000129	0.000191	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—ISYNA1—polycystic ovary syndrome	0.000129	0.000191	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—INS—polycystic ovary syndrome	0.000129	0.00019	CbGpPWpGaD
MACITENTAN—CYP3A4—Biological oxidations—POMC—polycystic ovary syndrome	0.000129	0.00019	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IGF1—polycystic ovary syndrome	0.000125	0.000184	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—AKT2—polycystic ovary syndrome	0.000125	0.000184	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HMMR—polycystic ovary syndrome	0.000123	0.000182	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.000123	0.000181	CbGpPWpGaD
MACITENTAN—ALB—Platelet activation, signaling and aggregation—VEGFA—polycystic ovary syndrome	0.000123	0.000181	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—LHB—polycystic ovary syndrome	0.00012	0.000176	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—SERPINE1—polycystic ovary syndrome	0.000119	0.000175	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HSD3B1—polycystic ovary syndrome	0.000118	0.000174	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—HSD3B2—polycystic ovary syndrome	0.000117	0.000172	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—NCOR1—polycystic ovary syndrome	0.000116	0.000172	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—VEGFA—polycystic ovary syndrome	0.000114	0.000168	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKR1C1—polycystic ovary syndrome	0.000113	0.000167	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—CYP1A1—polycystic ovary syndrome	0.00011	0.000163	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TEAD2—polycystic ovary syndrome	0.00011	0.000162	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKR1C2—polycystic ovary syndrome	0.00011	0.000162	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—LHB—polycystic ovary syndrome	0.000107	0.000158	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—HSD3B2—polycystic ovary syndrome	0.000105	0.000155	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SULT2A1—polycystic ovary syndrome	0.000104	0.000154	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKR1C1—polycystic ovary syndrome	0.000102	0.00015	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—RRM2—polycystic ovary syndrome	0.000101	0.000149	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—YAP1—polycystic ovary syndrome	9.72e-05	0.000143	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—IGF1—polycystic ovary syndrome	9.68e-05	0.000143	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—AKT2—polycystic ovary syndrome	9.67e-05	0.000143	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling by GPCR—IL6—polycystic ovary syndrome	9.55e-05	0.000141	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SULT2A1—polycystic ovary syndrome	9.35e-05	0.000138	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NAMPT—polycystic ovary syndrome	9.34e-05	0.000138	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	9.29e-05	0.000137	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP11A1—polycystic ovary syndrome	9.23e-05	0.000136	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PNPLA2—polycystic ovary syndrome	9.2e-05	0.000136	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—SERPINE1—polycystic ovary syndrome	9.19e-05	0.000136	CbGpPWpGaD
MACITENTAN—ALB—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	9.16e-05	0.000135	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—RRM2—polycystic ovary syndrome	9.05e-05	0.000134	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—YAP1—polycystic ovary syndrome	8.73e-05	0.000129	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SRD5A1—polycystic ovary syndrome	8.72e-05	0.000129	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—AKR1C3—polycystic ovary syndrome	8.71e-05	0.000129	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP17A1—polycystic ovary syndrome	8.58e-05	0.000127	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NAMPT—polycystic ovary syndrome	8.39e-05	0.000124	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—PPARG—polycystic ovary syndrome	8.34e-05	0.000123	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—STAR—polycystic ovary syndrome	8.32e-05	0.000123	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP11A1—polycystic ovary syndrome	8.28e-05	0.000122	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism of lipids and lipoproteins—POMC—polycystic ovary syndrome	8.22e-05	0.000121	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—VEGFA—polycystic ovary syndrome	8.15e-05	0.00012	CbGpPWpGaD
MACITENTAN—EDNRB—Signaling Pathways—IL6—polycystic ovary syndrome	7.88e-05	0.000116	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—AKR1C3—polycystic ovary syndrome	7.82e-05	0.000115	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP17A1—polycystic ovary syndrome	7.7e-05	0.000114	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—TH—polycystic ovary syndrome	7.42e-05	0.000109	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HMMR—polycystic ovary syndrome	7.42e-05	0.000109	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—SLC2A4—polycystic ovary syndrome	7.22e-05	0.000106	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HSD3B1—polycystic ovary syndrome	7.08e-05	0.000104	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP19A1—polycystic ovary syndrome	6.79e-05	0.0001	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—TH—polycystic ovary syndrome	6.66e-05	9.83e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—SLC2A4—polycystic ovary syndrome	6.48e-05	9.56e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—LHB—polycystic ovary syndrome	6.45e-05	9.52e-05	CbGpPWpGaD
MACITENTAN—ALB—Hemostasis—VEGFA—polycystic ovary syndrome	6.32e-05	9.32e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—HSD3B2—polycystic ovary syndrome	6.31e-05	9.3e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKR1C1—polycystic ovary syndrome	6.11e-05	9.01e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP19A1—polycystic ovary syndrome	6.09e-05	8.99e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—GNAS—polycystic ovary syndrome	6.06e-05	8.94e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—NCOR1—polycystic ovary syndrome	5.77e-05	8.51e-05	CbGpPWpGaD
MACITENTAN—EDNRA—Signaling Pathways—IL6—polycystic ovary syndrome	5.64e-05	8.32e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SULT2A1—polycystic ovary syndrome	5.62e-05	8.29e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—CYP1A1—polycystic ovary syndrome	5.47e-05	8.07e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—RRM2—polycystic ovary syndrome	5.45e-05	8.03e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—GNAS—polycystic ovary syndrome	5.44e-05	8.02e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—YAP1—polycystic ovary syndrome	5.25e-05	7.74e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—NCOR1—polycystic ovary syndrome	5.18e-05	7.64e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—MTHFR—polycystic ovary syndrome	5.1e-05	7.52e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NAMPT—polycystic ovary syndrome	5.04e-05	7.44e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP11A1—polycystic ovary syndrome	4.98e-05	7.35e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—CYP1A1—polycystic ovary syndrome	4.91e-05	7.24e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—AKR1C3—polycystic ovary syndrome	4.7e-05	6.94e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP17A1—polycystic ovary syndrome	4.63e-05	6.83e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—MTHFR—polycystic ovary syndrome	4.58e-05	6.75e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—PPARG—polycystic ovary syndrome	4.14e-05	6.1e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—POMC—polycystic ovary syndrome	4.08e-05	6.02e-05	CbGpPWpGaD
MACITENTAN—ALB—Metabolism—INS—polycystic ovary syndrome	4.06e-05	5.98e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—TH—polycystic ovary syndrome	4.01e-05	5.91e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—SLC2A4—polycystic ovary syndrome	3.9e-05	5.75e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—PPARG—polycystic ovary syndrome	3.71e-05	5.48e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP19A1—polycystic ovary syndrome	3.66e-05	5.4e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—POMC—polycystic ovary syndrome	3.66e-05	5.4e-05	CbGpPWpGaD
MACITENTAN—CYP2C19—Metabolism—INS—polycystic ovary syndrome	3.64e-05	5.37e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—GNAS—polycystic ovary syndrome	3.27e-05	4.82e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—NCOR1—polycystic ovary syndrome	3.12e-05	4.6e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—CYP1A1—polycystic ovary syndrome	2.95e-05	4.36e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—MTHFR—polycystic ovary syndrome	2.75e-05	4.06e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—PPARG—polycystic ovary syndrome	2.23e-05	3.29e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—POMC—polycystic ovary syndrome	2.2e-05	3.25e-05	CbGpPWpGaD
MACITENTAN—CYP3A4—Metabolism—INS—polycystic ovary syndrome	2.19e-05	3.23e-05	CbGpPWpGaD
